Lonza Group Ltd

1LONN

Company Profile

  • Business description

    Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.

  • Contact

    Muenchensteinerstrasse 38
    Basel4002
    CHE

    T: +41 613168111

    E: [email protected]

    https://www.lonza.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2026

    Employees

    16,866

Stocks News & Analysis

stocks

Why stocks sometimes fall for no obvious reason

How the private markets impact all equity investors.
stocks

Poor organic growth obscured by acquisition for ASX listed share

Sales dropped by 2% without impact of acquisition.
stocks

Nvidia dominance continues

Our view on the latest earnings report.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,877.2015.00-0.17%
CAC 408,115.7529.750.37%
DAX 4024,888.56281.791.15%
Dow JONES (US)50,579.70294.040.58%
FTSE 10010,466.2622.790.22%
HKSE25,606.03219.510.86%
NASDAQ26,343.9750.870.19%
Nikkei 22563,339.071,654.932.68%
NZX 50 Index12,991.31113.240.88%
S&P 5007,473.4727.750.37%
S&P/ASX 2008,657.0015.10-0.17%
SSE Composite Index4,112.9035.620.87%

Market Movers